April W. Armstrong, MD, MPH - Targeting the Burden of Moderate to Severe Psoriasis: A Visual Exploration of the Role of IL-17 Inhibitors in Improving Patient Care and Quality of Life - a podcast by PVI, PeerView Institute for Medical Education

from 2021-05-18T18:00

:: ::

Go online to PeerView.com/ECW860 to view the activity, download slides and practice aids, and complete the post-test to earn credit. In this activity, an expert in dermatology discusses the role of IL-17 inhibitors in the treatment of psoriasis. Upon completion of this activity, participants should be better able to: Discuss the impact of psoriasis on patient quality of life, Outline the role of IL-17 in the pathophysiology of psoriasis, Assess data regarding the efficacy and safety of IL-17 inhibitors for the treatment of moderate to severe psoriasis, Incorporate agents targeting IL-17 into appropriate and effective treatment plans for individual patients with moderate to severe psoriasis.

Further episodes of PeerView Family Medicine

Further podcasts by PVI, PeerView Institute for Medical Education

Website of PVI, PeerView Institute for Medical Education